Amy E. Medlock

1.8k total citations
31 papers, 1.2k citations indexed

About

Amy E. Medlock is a scholar working on Molecular Biology, Cell Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Amy E. Medlock has authored 31 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 8 papers in Cell Biology and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Amy E. Medlock's work include Porphyrin Metabolism and Disorders (22 papers), Heme Oxygenase-1 and Carbon Monoxide (14 papers) and Hemoglobin structure and function (8 papers). Amy E. Medlock is often cited by papers focused on Porphyrin Metabolism and Disorders (22 papers), Heme Oxygenase-1 and Carbon Monoxide (14 papers) and Hemoglobin structure and function (8 papers). Amy E. Medlock collaborates with scholars based in United States, Australia and Czechia. Amy E. Medlock's co-authors include Harry A. Dailey, Tamara A. Dailey, Jason R. Marcero, William N. Lanzilotta, John D. Phillips, James A. Wohlschlegel, Michael A. Cahill, Ajay A. Vashisht, C.-K. Wu and Amit R. Reddi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Amy E. Medlock

31 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy E. Medlock United States 19 928 249 151 150 120 31 1.2k
Kerstin Diekert Germany 12 1.2k 1.3× 95 0.4× 35 0.2× 36 0.2× 246 2.0× 15 1.6k
Heeyong Yoon United States 13 643 0.7× 92 0.4× 36 0.2× 28 0.2× 215 1.8× 21 940
Wing-Hang Tong United States 13 1.1k 1.2× 90 0.4× 338 2.2× 25 0.2× 716 6.0× 18 1.8k
B. Goossen Germany 11 917 1.0× 188 0.8× 439 2.9× 58 0.4× 23 0.2× 13 1.4k
Annette Biederbick Germany 9 532 0.6× 169 0.7× 72 0.5× 12 0.1× 120 1.0× 10 1.0k
Ermanna Rovida Italy 20 686 0.7× 146 0.6× 738 4.9× 53 0.4× 17 0.1× 47 1.5k
Takehiro Yamamoto Japan 18 960 1.0× 163 0.7× 27 0.2× 104 0.7× 21 0.2× 46 1.6k
Javier Garcia Barriocanal United States 9 719 0.8× 255 1.0× 245 1.6× 17 0.1× 25 0.2× 12 1.3k
Oleksandr Gakh United States 21 1.5k 1.6× 297 1.2× 91 0.6× 5 0.0× 239 2.0× 35 1.7k
Maria Warren United States 8 1.5k 1.6× 46 0.2× 63 0.4× 59 0.4× 8 0.1× 8 1.9k

Countries citing papers authored by Amy E. Medlock

Since Specialization
Citations

This map shows the geographic impact of Amy E. Medlock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy E. Medlock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy E. Medlock more than expected).

Fields of papers citing papers by Amy E. Medlock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy E. Medlock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy E. Medlock. The network helps show where Amy E. Medlock may publish in the future.

Co-authorship network of co-authors of Amy E. Medlock

This figure shows the co-authorship network connecting the top 25 collaborators of Amy E. Medlock. A scholar is included among the top collaborators of Amy E. Medlock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy E. Medlock. Amy E. Medlock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dailey, Harry A., et al.. (2023). Proteomic Analysis of Ferrochelatase Interactome in Erythroid and Non-Erythroid Cells. Life. 13(2). 577–577. 3 indexed citations
2.
Hill, Janette R., et al.. (2023). Exploring Academic Performance of Medical Students in an Integrated Hybrid Curriculum by Gender. Medical Science Educator. 33(2). 353–357. 2 indexed citations
3.
Dailey, Harry A., et al.. (2022). Ferrochelatase: Mapping the Intersection of Iron and Porphyrin Metabolism in the Mitochondria. Frontiers in Cell and Developmental Biology. 10. 894591–894591. 26 indexed citations
4.
Dailey, Harry A. & Amy E. Medlock. (2022). A primer on heme biosynthesis. Biological Chemistry. 403(11-12). 985–1003. 20 indexed citations
5.
Medlock, Amy E., et al.. (2022). Prime Real Estate: Metals, Cofactors and MICOS. Frontiers in Cell and Developmental Biology. 10. 892325–892325. 9 indexed citations
6.
Bohovych, Iryna, Jennifer L. Fox, William N. Lanzilotta, et al.. (2021). Mitochondrial contact site and cristae organizing system (MICOS) machinery supports heme biosynthesis by enabling optimal performance of ferrochelatase. Redox Biology. 46. 102125–102125. 22 indexed citations
7.
Martinez-Guzman, Osiris, et al.. (2020). Mitochondrial–nuclear heme trafficking in budding yeast is regulated by GTPases that control mitochondrial dynamics and ER contact sites. Journal of Cell Science. 133(10). 32 indexed citations
8.
Dailey, Harry A., et al.. (2019). The mitochondrial heme metabolon: Insights into the complex(ity) of heme synthesis and distribution. Molecular Genetics and Metabolism. 128(3). 198–203. 34 indexed citations
9.
Marcero, Jason R., J. Alan Maschek, James E. Cox, et al.. (2018). Glutamine via α-ketoglutarate dehydrogenase provides succinyl-CoA for heme synthesis during erythropoiesis. Blood. 132(10). 987–998. 62 indexed citations
10.
Cahill, Michael A. & Amy E. Medlock. (2017). Thoughts on interactions between PGRMC1 and diverse attested and potential hydrophobic ligands. The Journal of Steroid Biochemistry and Molecular Biology. 171. 11–33. 45 indexed citations
11.
Vashisht, Ajay A., Jason R. Marcero, Jeremy L. Praissman, et al.. (2016). A Novel Role for Progesterone Receptor Membrane Component 1 (PGRMC1): A Partner and Regulator of Ferrochelatase. Biochemistry. 55(37). 5204–5217. 85 indexed citations
12.
Medlock, Amy E., Jason R. Marcero, Ajay A. Vashisht, et al.. (2015). Identification of the Mitochondrial Heme Metabolism Complex. PLoS ONE. 10(8). e0135896–e0135896. 85 indexed citations
13.
Medlock, Amy E., et al.. (2014). Managing Micronutrient Nutrition: The Vitamin B12 Exemplar. MedEdPORTAL. 2 indexed citations
14.
Medlock, Amy E., et al.. (2012). Identification and Characterization of Solvent-Filled Channels in Human Ferrochelatase. Biochemistry. 51(27). 5422–5433. 13 indexed citations
15.
Medlock, Amy E., Michael Carter, Tamara A. Dailey, Harry A. Dailey, & William N. Lanzilotta. (2009). Product Release Rather than Chelation Determines Metal Specificity for Ferrochelatase. Journal of Molecular Biology. 393(2). 308–319. 45 indexed citations
16.
Medlock, Amy E., et al.. (2007). A π-Helix Switch Selective for Porphyrin Deprotonation and Product Release in Human Ferrochelatase. Journal of Molecular Biology. 373(4). 1006–1016. 60 indexed citations
17.
Medlock, Amy E., et al.. (2007). Substrate interactions with human ferrochelatase. Proceedings of the National Academy of Sciences. 104(6). 1789–1793. 84 indexed citations
18.
Pondarré, Corinne, Brendan Antiochos, Dean R. Campagna, et al.. (2006). The mitochondrial ATP-binding cassette transporter Abcb7 is essential in mice and participates in cytosolic iron–sulfur cluster biogenesis. Human Molecular Genetics. 15(6). 953–964. 174 indexed citations
19.
Medlock, Amy E., et al.. (2002). A mouse model for South African (R59W) variegate porphyria: construction and initial characterization.. PubMed. 48(1). 71–8. 15 indexed citations
20.
Medlock, Amy E. & Harry A. Dailey. (1996). Human Coproporphyrinogen Oxidase Is Not a Metalloprotein. Journal of Biological Chemistry. 271(51). 32507–32510. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026